newsfilter
← Latest News
Business Wire·

Syros Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

-- On track to announce initial randomized data from SELECT-AML-1 trial in 4Q 2023 -- -- Expect to complete enrollment of 190 patients in SELECT-MDS-1 trial in 4Q 2023; pivotal CR data expected in 3Q 2024 -- --